818
Participants
Start Date
May 31, 2016
Primary Completion Date
October 31, 2019
Study Completion Date
January 31, 2020
rhTNK-tPA
Dose:16mg; Mode of admin: Single bolus Enoxaparin or unfractionated heparin for anticoagulant therapy, clopidogrel and aspirin for antiplatelet therapy before fibrinolytic therapy.
alteplase
Dose:50mg; Mode of admin: administered as an 8-mg initial IV bolus followed by an infusion of 42 mg over the next 90 minutes Enoxaparin or unfractionated heparin for anticoagulant therapy, clopidogrel and aspirin for antiplatelet therapy before fibrinolytic therapy.
Guangzhou Recomgen Biotech Co., Ltd., Guangzhou
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
Peking University
OTHER
CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
INDUSTRY